$TVRD

$0.87 +$0.02 (2.76%) Close

$TVRD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$TVRD Management Team

Mr. Sujal Shah

Independent Chairman of the Board

Age 50

Compensation -

Sex Male

Dr. Imran Alibhai

Chief Executive Officer

Director

Age 49

Compensation -

Sex Male

Mr. Dan Conn

Chief Financial Officer

Age 58

Compensation -

Sex Male

Dr. Jeffrey Larson

Senior Vice President - Research & Development

Age 63

Compensation -

Sex Male

Mr. Stephen O'Brien

Vice President - Finance

Corporate Controller

Age -

Compensation -

Sex Male

Dr. Yixin Chen

Vice President - Chemistry

Manufacturing and Controls

Age -

Compensation -

Sex Male

Dr. John Kauh

Chief Medical Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Sujal Shah Independent Chairman of the Board	50	-	Male
Dr. Imran Alibhai Chief Executive Officer Director	49	-	Male
Mr. Dan Conn Chief Financial Officer	58	-	Male
Dr. Jeffrey Larson Senior Vice President - Research & Development	63	-	Male
Mr. Stephen O'Brien Vice President - Finance Corporate Controller	-	-	Male
Dr. Yixin Chen Vice President - Chemistry Manufacturing and Controls	-	-	Male
Dr. John Kauh Chief Medical Officer	-	-	Male

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

5 of 6

stated in the proxy

Average tenure

Not stated

from year joined

CEO also chairs the board

Sujal Shah

Director	Age	On board	Independent	Committees	Other public boards	Pay
Imran Alibhai, Ph.D. CEO	Not stated	Not stated	Not independent	None stated	None stated	Paid as CEO
Sujal Shah Board chair	Not stated	Not stated	Independent	None stated	None stated	Not stated
Cynthia Smith	Not stated	Not stated	Independent	None stated	Agios Pharmaceuticals, Inc., Akebia Therapeutics, Inc., Protara Therapeutics, Inc., Spero Therapeutics, Inc.	Not stated
Wallace L. Hall, Jr.	Not stated	Not stated	Independent	Audit Committee	None stated	Not stated
Susan Shiff, Ph.D.	Not stated	Not stated	Independent	Audit Committee	None stated	Not stated
Michael S. Wyzga	Not stated	Not stated	Independent	Audit Committee · Chair	GenSight Biologics S.A.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$TVRD Management Team

Mr. Sujal Shah

Dr. Imran Alibhai

Mr. Dan Conn

Dr. Jeffrey Larson

Mr. Stephen O'Brien

Dr. Yixin Chen

Dr. John Kauh

Board of Directors

Related-party transactions

No related-party transactions disclosed